4Committee G.2003 European society of hypertension-european society of cardiology guidelines for the management of arterial hypertension[J].J Hypertension,2003,21:1011-53.
5The Seventh Report of the Joint National Committee on Prevention,Detection,Evaluation,and Treatment of High Blood Pressure(JNCT):is it really practical[J]?Natl Med J India,2004,17(4):227.
6Whitworth JA:World Health Organization,International Society of Hypertension Writing Group.2003 World Health Organization (WHO) /International Society of Hypertension(ISH) statement on management of hypertension[J].J Hypertens,2003,21(11):1983-92.
8JoelG.Hardman Lee E.Limbird 金有豫主译.Goodman & Gilman’s The Pharmacological Basis of Therapeutics,10/e[M].古德曼吉尔曼治疗学的药理学基础.第10版[M].北京:人民卫生出版社,..
9Guide to Good Prescribing.A Practical Manual.Geneva:World Health Organization;1994.http://www.who.int/medicines/library/par/ggprescribing/who-dap-94-11en.pdf.
10Hill SR,Smith AJ.First-Line medicines in the treatment of hypertension[J].Australian Prescriber,2005,28:34-7.
4Quinzler R, Gasse C, Schneider A, et al.The frequency ofinappropriate tablet splitting in primary care [J].Eur JClin Pharmacol, 2006,62(12) : 1 065.
5Shah RB,Collier JS,Sayeed VA,et al. Tablet Splitting ofa Narrow Therapeutic Index Drug : A Case with Levothyrox-ine Sodium [Y\. AAPSPharm Sci Tech,2010,11(3) : 1 359.
